Epigenetic modifier drugs trigger widespread transcription of endogenous retroviruses

A study in this issue demonstrates that epigenome-modifying drugs used in cancer chemotherapy induce transcription from thousands of previously unannotated transcription start sites, most of which are derived from ancient endogenous retroviruses (ERVs). This work, coupled with previous related findi...

Ausführliche Beschreibung